Potential use of the hemagglutinin-neuraminidase glycoprotein of newcastle disease virus expressed in Rachiplusia nu larvae as anImmunogen for chickens

Clinical and Vaccine Immunology

Volumn 16, Issue 5, 2009, Pages 775-778

  Zoth, Silvina Chimeno ^a,b   Gómez, Evangelina ^a,b   Carballeda, Juan Manuel ^a   Taboga, Oscar ^a,b   Carrillo, Elisa ^a,b   Berinstein, Analía ^a,b  

^a INSTITUTO NACIONAL DE TECNOLOGÍA AGROPECUARIA INTA   (Argentina)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

HN PROTEIN; IMMUNOGLOBULIN G; NEUTRALIZING ANTIBODY; NEWCASTLE DISEASE VACCINE; RECOMBINANT ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTHROPOD LARVA; ARTICLE; CHICKEN; CONTROLLED STUDY; IMMUNE RESPONSE; LEPIDOPTERA; NEWCASTLE DISEASE PARAMYXOVIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; VIRUS EXPRESSION; VIRUS INFECTION;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANTIBODIES, VIRAL; CHICKENS; HN PROTEIN; INSECTS; LARVA; NEUTRALIZATION TESTS; NEWCASTLE DISEASE; NEWCASTLE DISEASE VIRUS; POULTRY DISEASES; VACCINES, SYNTHETIC; VIRAL VACCINES;

EID: 66849084276     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00432-08     Document Type: Article

References (24)

1. Berinstein, A., C. Vazquez-Rovere, S. Asurmendi, E. Gomez, F. Zanetti, O. Zabal, A. Tozzini, D. Conte Grand, O. Taboga, G. Calamante, H. Barrios, E. Hopp, and E. Carrillo. 2005. Mucosal and systemic immunization by Newcastle Disease Virus (NDV) transgenic plants as antigens. Vaccine 23:5583-5589.
2. Boursnell, M. E. G., P. F. Green, J. I. A. Campbell, A. Deuter, R. W. Peters, F. M. Tomley, A. C. R. Samson, P. Chambers, P. T. Emmerson, and M. M. Binns. 1990. Insertion of the fusion gene from Newcastle disease virus into a non-essential region in the terminal repeats of fowlpox virus and demonstration of protective immunity induced by the recombinant. J. Gen. Virol. 71:621-628.
3. Chen, J., X. F. Wu, and Y. Z. Zhang. 2006. Expression, purification and characterization of human GM-CSF using silkworm pupae (Bombyx mori)as a bioreactor. J. Biotechnol. 123:236-247.
4. Chimeno Zoth, S., E. Goomez, E. Carrillo, and A. Berinstein. 2008. Further characterization of chicken's immune response to Newcastle disease virus conventional vaccines: locally produced mucosal IgG. Braz. J. Med. Biol. Res. 41:318-323.
5. Clarke, T. E., and R. J. Clem. 2002. Lack of involvement of haemocytes in the establishment and spread of infection in Spodoptera frugperda larvae infected with the baculovirus Autographa californica M nucleopolyhedrovirus by intrahaemocoelic injection. J. Gen. Virol. 83:1565-1572.
6. de Leeuw, O. S., and B. P. H. Peeters. 1999. Complete nucleotide sequence of Newcastle disease virus: for the existence of a new genus within the subfamily Paramyxovirinae. J. Gen. Virol. 80:131-136.
7. Ferrer, F., S. Chimeno Zoth, G. Calamante, and O. Taboga. 2007. Induction of virus-neutralizing antibodies by immunization with Rachiplusia nu per os infected with a recombinant baculovirus expressing the E2 glycoprotein of bovine viral diarrhea virus. J. Virol. Methods 146:424-427.
8. Harlow, E., and D. Lane. 1988. Antibodies. A laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
9. Kamiya, N., M. Niikura, M. Ono, C. Kai, Y. Matsuura, and T. Mikami. 1994. Protective effect of individual glycoproteins of Newcastle disease virus expressed in insect cells: the fusion protein derived from an avirulent strain had lower protective effect. Virus Res. 32:373-379.
10. Karaca, K., J. M. Sharma, B. J. Winslow, D. E. Junker, S. Reddy, M.Cochran, and J. McMillen. 1998. Recombinant fowlpoxviruses coexpressing chicken type IIFN and Newcastle disease virus HN and F genes: influence of IFN on protective efficacy and humoral responses of chickens following in ovo or post-hatch administration of recombinant viruses. Vaccine 16:1496-1503.
11. King, D. J. 1996. Avian paramyxovirus type 1 from pigeons: isolate charac-terization and pathogenicity after chicken or embryo passage of selected isolates. Avian Dis. 40:707-714.
12. Kost, T. A., J. P. Condreay, and D. L. Jarvis. 2005. Baculoviruses as versatile vectors for protein expression in insect and mammalian cells. Nat. Biotech-nol. 23:567-574.
13. Loopez, M. G., A. Peralta, A. Berinstein, N. Fondevila, E. Carrillo, and O. Taboga. 2005. High-level expression of recombinant 3AB1 non-structural protein from FMDV in insect larvae. J. Virol. Methods 124:221-224.
14. Luckow, V. L., and M. D. Summers. 1988. Trends in the development of baculovirus expression vectors. Bio/Technology 6:47-55.
15. Maniatis, T., E. F. Fritsch, and J. Sambrook. 1987. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor,NY.
16. Muneta, Y., H. Nagaya, Y. Minagawa, C. Enomoto, S. Matsumoto, and Y. Mori. 2004. Expression and one-step purification of bovine interleukin-21 (IL-21) in silkworms using a hybrid baculovirus expression system. Biotech-nol. Lett. 26:1453-1458.
17. Nagy, E., P. J. Krell, G. C. Dulac, and J. B. Derbyshire. 1991. Vaccination against Newcastle disease with a recombinant baculovirus hemagglutinin- neuraminidase subunit vaccine. Avian Dis. 35:585-590.
18. Nishino, Y., M. Niikura, T. Suwa, M. Onuma, B. Gotoh, Y. Nagai, and T.Mikami. 1991. Analysis of the protective effect of the haemagglutinin-neur- aminidase protein in Newcastle disease virus infection. J. Gen. Virol. 72:1187-1190.
19. O'Reilly, D., L. K. Miller, and V. A. Luckow. 1994. Baculovirus expression vectors, a laboratory manual. W. H. Freeman & Company, New York, NY.
20. Panda, A., S. Elankumaran, S. Krishnamurthy, Z. Huang, and S. K. Sarnal. 2004. Loss of N-linked glycosylation from the hemagglutinin- neuraminidase protein alters virulence of Newcastle disease virus. J. Virol. 78:4965-4975.
21. Poerez-Filgueira, D. M., F. Gonzaolez-Camacho, C. Gallardo, P. Resino-Tala- voan, E. Blanco, E. Goomez-Casado, C. Alonso, and J. M. Escribano. 2006. Optimization and validation of recombinant serological test for African swine fever diagnosis based on detection of the p30 protein produced in Trichoplusia ni larvae. J. Clin. Microbiol. 44:3114-3121.
22. Poerez-Filgueira, D. M., P. Resino-Talavaon, C. Cubillos, I. Angulo, M. G.Barderas, J. Barcena, and J. M. Escribano. 2007. Developmentofalow- cost, insect larvae-derived recombinant subunit vaccine against RHDV. Virology 364:422-430.
23. Reynolds, D. L., and A. D. Maraqa. 2000. Protective immunity against Newcastle disease: the role of antibodies specific to Newcastle disease virus polypeptides. Avian Dis. 44:138-144.
24. Taylor, J., C. Edbauer, A. Rey-Senelonge, J. F. Bouquet, E. Norton, S.Goebel, P. Desmettre, and E. Paoletti. 1990. Newcastle disease virus fusion protein expressed in a fowlpox virus recombinant confers protection in chickens. J. Virol. 64:1441-1450.